These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8920706)

  • 21. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
    Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
    J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine.
    Kapikian AZ; Hoshino Y; Chanock RM; Perez-Schael I
    Arch Virol Suppl; 1996; 12():163-75. PubMed ID: 9015113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
    Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
    Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
    Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.
    Flores J; Perez-Schael I; Gonzalez M; Garcia D; Perez M; Daoud N; Cunto W; Chanock RM; Kapikian AZ
    Lancet; 1987 Apr; 1(8538):882-4. PubMed ID: 2882289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
    Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
    J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus.
    Parashar UD; Bresee JS; Gentsch JR; Glass RI
    Emerg Infect Dis; 1998; 4(4):561-70. PubMed ID: 9866732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus-based reassortant vaccine.
    Clemens J; Keckich N; Naficy A; Glass R; Rao M
    Epidemiol Rev; 1999; 21(1):24-42. PubMed ID: 10520471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
    Joensuu J; Koskenniemi E; Vesikari T
    Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.
    Flores J; Perez-Schael I; Blanco M; Rojas AM; Alfonzo E; Crespo I; Cunto W; Pittman AL; Kapikian AZ
    J Clin Microbiol; 1993 Sep; 31(9):2439-45. PubMed ID: 8408569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine.
    Lanata CF; Black RE; del Aguila R; Gil A; Verastegui H; Gerna G; Flores J; Kapikian AZ; Andre FE
    J Infect Dis; 1989 Mar; 159(3):452-9. PubMed ID: 2536789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
    Losonsky GA; Rennels MB; Kapikian AZ; Midthun K; Ferra PJ; Fortier DN; Hoffman KM; Baig A; Levine MM
    Pediatr Infect Dis; 1986; 5(1):25-9. PubMed ID: 3003715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis.
    Pang XL; Joensuu J; Hoshino Y; Kapikian AZ; Vesikari T
    J Clin Virol; 1999 Jun; 13(1-2):9-16. PubMed ID: 10405887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
    Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
    Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of rotavirus vaccine trials in Finland.
    Vesikari T; Joensuu J
    J Infect Dis; 1996 Sep; 174 Suppl 1():S81-7. PubMed ID: 8752295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants.
    Pichichero ME; Marsocci SM; Francis AB; Green JL; Disney FA; Rennels MB; Lewis ED; Sugarman L; Losonsky GA; Zito E
    Vaccine; 1993; 11(7):747-53. PubMed ID: 8393606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetravalent rhesus rotavirus vaccine in young infants.
    Kobayashi M; Thompson J; Tollefson SJ; Reed GW; Wright PF
    J Infect Dis; 1994 Nov; 170(5):1260-3. PubMed ID: 7963722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
    Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
    Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.